Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004983644 | SCV005596901 | uncertain significance | Inborn genetic diseases | 2024-11-30 | criteria provided, single submitter | clinical testing | The p.P93L variant (also known as c.278C>T), located in coding exon 2 of the GATA2 gene, results from a C to T substitution at nucleotide position 278. The proline at codon 93 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |